A once-daily drug regimen comprising three leading antiretroviral drugs

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 372, 2002 , pp. 5-5(1)

Publisher: Adis International

Keywords: Bristol-Myers-Squibb; Didanosine, therapeutic use; Efavirenz, therapeutic use; HIV-infections, treatment; Lamivudine, therapeutic use; Quality-of-life; Trial-result-clinical

Language: English

Document Type: Short communication

Publication date: 2002-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers